[Skip to Content]
[Skip to Content Landing]
Article
November 1937

PNEUMONIA DUE TO BACILLUS FRIEDLÄNDERI: A REPORT ON FORTY-ONE PATIENTS, WITH CONSIDERATION OF SPECIFIC SERUM THERAPY

Author Affiliations

Clinical Professor of Medicine, New York University College of Medicine.; Residents, Service for Acute Disease of Respiratory Tract, the Harlem Hospital NEW YORK

From the Littauer Pneumonia Research Fund, New York University; the Medical Service, the Harlem Hospital, and the Bureau of Laboratories, the Department of Health.

Arch Intern Med (Chic). 1937;60(5):735-752. doi:10.1001/archinte.1937.00180050002001
Abstract

The existence of pulmonary disease attributable to Bacillus Friedländeri has been recognized for a number of years. Most of the previous reports have been based on isolated cases or small groups of cases, with two or three outbreaks approaching epidemic proportions. Examination of these reports reveals that they have been concerned with various features of the organism and the disease.

There have been extensive bacteriologic, cultural and immunologic studies of Friedländeri, with more recent work on their subdivision into several morphologically identical but serologically distinct groups. These have been further concerned with the etiologic significance of the presence of B. Friedländeri in diseased pulmonary tissue and its relative incidence in the pneumonias, in extrapulmonary diseases and in the carrier state.

Clinical study has distinguished the chronic form of the disease, which simulates pulmonary tuberculosis, from the acute fulminating form, with a uniformly high mortality rate, like that of pneumococcic lobar

×